Chlortetracycline

Chlortetracycline

File:Chlortetracycline.svg
Clinical data
Routes of administration	Oral, IV, topical
ATC code	D06AA02 (WHO) A01AB21 (WHO)
Pharmacokinetic data
Bioavailability	30%
Protein binding	50 to 55%
Metabolism	Hepatic (75%)
Elimination half-life	5.6 to 9 hours
Excretion	Renal and biliary
Identifiers
IUPAC name (2Z,4S,4aS,5aS,6S,12aS)-2-(amino-hydroxy- methylidene)-7-chloro-4-dimethylamino-6,10,11,12a- tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene- 1,3,12-trione
CAS Number	57-62-5
PubChem CID	5280963
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C22H23ClN2O8
Molar mass	478.879 g/mol

WikiDoc Resources for Chlortetracycline
Articles
Most recent articles on Chlortetracycline Most cited articles on Chlortetracycline Review articles on Chlortetracycline Articles on Chlortetracycline in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Chlortetracycline Images of Chlortetracycline Photos of Chlortetracycline Podcasts & MP3s on Chlortetracycline Videos on Chlortetracycline
Evidence Based Medicine
Cochrane Collaboration on Chlortetracycline Bandolier on Chlortetracycline TRIP on Chlortetracycline
Clinical Trials
Ongoing Trials on Chlortetracycline at Clinical Trials.gov Trial results on Chlortetracycline Clinical Trials on Chlortetracycline at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Chlortetracycline NICE Guidance on Chlortetracycline NHS PRODIGY Guidance FDA on Chlortetracycline CDC on Chlortetracycline
Books
Books on Chlortetracycline
News
Chlortetracycline in the news Be alerted to news on Chlortetracycline News trends on Chlortetracycline
Commentary
Blogs on Chlortetracycline
Definitions
Definitions of Chlortetracycline
Patient Resources / Community
Patient resources on Chlortetracycline Discussion groups on Chlortetracycline Patient Handouts on Chlortetracycline Directions to Hospitals Treating Chlortetracycline Risk calculators and risk factors for Chlortetracycline
Healthcare Provider Resources
Symptoms of Chlortetracycline Causes & Risk Factors for Chlortetracycline Diagnostic studies for Chlortetracycline Treatment of Chlortetracycline
Continuing Medical Education (CME)
CME Programs on Chlortetracycline
International
Chlortetracycline en Espanol Chlortetracycline en Francais
Business
Chlortetracycline in the Marketplace Patents on Chlortetracycline
Experimental / Informatics
List of terms related to Chlortetracycline

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Chlortetracycline (trade name Aureomycin®, Lederle) is a tetracycline antibiotic, and was the first tetracycline to be discovered. It was discovered in 1945 by Dr Benjamin Duggar in a soil sample from Sanborn Field at the University of Missouri, yielding an actinomycete, Streptomyces aureofaciens (hence the name Aureomycin). In veterinary medicine, it is commonly used to treat conjunctivitis in cats.